共 134 条
[1]
Ly KN(2012)The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007 Ann Intern Med 156 271-278
[2]
Xing J(2008)Risk factors for developing a cutaneous injection-related infection among injection drug users: a cohort study BMC Public Health 8 405-1259
[3]
Klevens RM(2008)Estimated drug overdose deaths averted by North America’s first medically-supervised safer injection facility PLoS One 3 e3351-472
[4]
Jiles RB(2016)A socio-structural approach to preventing injection drug use initiation: rationale for the PRIMER study Harm Reduct J. 13 25-1163
[5]
Ward JW(2015)Next steps in research on injection initiation incidence and prevention Addiction 110 1258-661
[6]
Holmberg SD(2013)Risk factors for progression to regular injection drug use among street-involved youth in a Canadian setting Drug Alcohol Depend 133 468-86
[7]
Lloyd-Smith E(1994)Risk factors for the transition from noninjection to injection drug use and accompanying AIDS risk behavior in a cohort of drug users Am J Epidemiol 139 1153-167
[8]
Wood E(1996)Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses Am J Public Health 86 655-726
[9]
Zhang R(1999)HIV prevalence and risk behaviors among new initiates into injection drug use over the age of 40 years old Drug Alcohol Depend 54 83-54
[10]
Tyndall MW(2000)Sex- and drug-related risk among populations of younger and older injection drug users in adjacent neighborhoods in San Francisco J Acquir Immune Defic Syndr 24 162-727